(Q38326385)

2 September 2017

Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and osteoblast-enriched cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1414501

24 September 2022

0 references

E. Canalis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1414501

24 September 2022

L. Avioli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1414501

24 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1414501

24 September 2022

publication date

1 September 1992

1 reference

Journal of Bone and Mineral Research

2 September 2017

1 reference

2 September 2017

7

1 reference

2 September 2017

9

1 reference

2 September 2017

1085-1092

1 reference

In vitro immunosuppressive potency of deflazacort, a new bone-sparing corticosteroid on T lymphocytes, NK and K cells

2 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJBMR.5650070912

Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FJBMR.5650070912

21 January 2018

Identifiers

DOI

10.1002/JBMR.5650070912

1 reference

2 September 2017

1 reference